In a metastatic murine model of colon cancer, treatment with an anti-EREG antibody induced antitumor activity against tumors derived from EREG-expressing LGR5-positive cells [102], thereby suggesting that targeting EREG is effective in defeating cancer stemness and chemoresistance. This evidence concerns the gene EREG and colonic neoplasm.